TRPC5
Basic information
Region (hg38): X:111768011-112082776
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder (Limited), mode of inheritance: XL
ClinVar
This is a list of variants' phenotypes submitted to
- TRPC5-related_disorder (113 variants)
- not_specified (44 variants)
- not_provided (12 variants)
- Intellectual_disability (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRPC5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000012471.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 52 | 58 | ||||
| missense | 75 | 80 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 78 | 57 | 5 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TRPC5 | protein_coding | protein_coding | ENST00000262839 | 10 | 308462 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.00 | 0.000270 | 125411 | 1 | 2 | 125414 | 0.0000120 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.27 | 197 | 375 | 0.525 | 0.0000288 | 6435 |
| Missense in Polyphen | 65 | 175.8 | 0.36975 | 2948 | ||
| Synonymous | -0.413 | 146 | 140 | 1.04 | 0.0000104 | 1869 |
| Loss of Function | 4.72 | 1 | 27.9 | 0.0358 | 0.00000213 | 484 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000761 | 0.0000615 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000132 | 0.00000882 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000549 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Thought to form a receptor-activated non-selective calcium permeant cation channel. Probably is operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. Has also been shown to be calcium-selective (By similarity). May also be activated by intracellular calcium store depletion. {ECO:0000250, ECO:0000269|PubMed:16284075}.;
- Pathway
- Axon guidance - Homo sapiens (human);ion channels and their functional role in vascular endothelium;Stimuli-sensing channels;Ion channel transport;Transport of small molecules;TRP channels
(Consensus)
Recessive Scores
- pRec
- 0.174
Intolerance Scores
- loftool
- 0.0223
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.51
Haploinsufficiency Scores
- pHI
- 0.154
- hipred
- Y
- hipred_score
- 0.792
- ghis
- 0.406
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0289
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trpc5
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- calcium ion transport;manganese ion transport;positive regulation of cytosolic calcium ion concentration;nervous system development;positive regulation of cell population proliferation;positive regulation of peptidyl-threonine phosphorylation;neuron differentiation;positive regulation of axon extension;negative regulation of dendrite morphogenesis;regulation of cytosolic calcium ion concentration;calcium ion transmembrane transport;regulation of membrane hyperpolarization
- Cellular component
- cytoplasm;plasma membrane;integral component of plasma membrane;dendrite;growth cone;cation channel complex;calcium channel complex;neuronal cell body;membrane raft
- Molecular function
- actin binding;calcium channel activity;protein binding;store-operated calcium channel activity;clathrin binding;actinin binding;ATPase binding;inositol 1,4,5 trisphosphate binding